Dermata Therapeutics, Inc. (DRMA)
$0.66-23.26%Close
SELLCRISIS · day 4
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $449,828
- Beta
- 0.66
- P/E (TTM)
- -0.15
- Short % float
- 16.95%
- Days to cover
- 3.6
- SI change
- -29.6%
- 1W
- -41.07%
- 1M
- -41.59%
- vs SPY 1W
- -40.93%
- vs SPY 1M
- -44.10%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
EARNINGS HISTORY
LOADING…Loading earnings…
Company news
FAQ
- What is LOPJLB’s current signal on DRMA?
- LOPJLB’s latest quantitative signal on Dermata Therapeutics, Inc. (DRMA) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is DRMA in?
- Dermata Therapeutics, Inc. (DRMA) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Dermata Therapeutics, Inc. (DRMA) do?
- Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States. The company develops direct-to-consumer skincare products, including foundation treatment products for skin renewal and clearing treatment products for the treatment of acne under the Tome brand. Dermata Therapeutics, Inc. was incorporated …